Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008701/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
- Thirty six patients suffering from active rheumatoid arthritis despite continued
treatment with methotrexate will be evaluated for improvement of disease activity when
taking GLPG0634 or matching placebo for 4 weeks.
- During the course of the study, patients will also be examined for any side effects that
may occur, and the amount of GLPG0634 present in the blood as well as the effects of
GLPG0634 on disease- and mechanism of action-related parameters in the blood will be
determined.
提供机构：
Vivli
创建时间：
2023-01-03
